Gorman Kevin Charles

Avg. Two Year Performance

No purchase track record
(17%) Avg. Sale Return
(8%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(8%)(6%)(14%)(8%)(17%)
Sale Success Rate11 of 2911 of 2910 of 299 of 293 of 29
Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 514.6K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 8.39K shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--